Viagra

ApprovedSmall molecule

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Viagra is one of 103 small molecule programs targeting Erectile Dysfunction. It is currently in Approved.

Indications

Total Trials

Active Trials

102

Competitors

Pipeline

Status by Indication[3][1]

Indication

Erectile DysfunctionActive, not recruiting

Benign Prostatic HyperplasiaActive, not recruiting

AnemiaActive, not recruiting

Erectile DysfunctionApproved

Active, not recruiting

Benign Prostatic HyperplasiaApproved

Active, not recruiting

AnemiaApproved

Active, not recruiting

Competition

Competitive Landscape

272 competitors in Anemia

#DrugCompanyPhaseTrials

Fludara

Sanofi

Phase 3

1 2

Vermox

WWim Janssens

Phase 3

1 3

Sandostatin

Sun Pharma

Phase 3

1 4

Imbruvica

PPharmacyclics LLC.

Phase 3

1 5

LNP023

Novartis

Phase 3

1 6

Viagra

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Approved

1 7

Ferrous Sulphate

VVifor Pharma

Phase 3

3 8

Epoetin

Roche

Phase 3

5 9

HRS-5965

CChengdu Suncadia Medicine Co., Ltd.

Phase 3

1 10

Aranesp

Amgen

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Erectile Dysfunction6 trials

Use of Sildenafil (Viagra) in Diabetic Men With Erectile Dysfunction: the Impact on Blood Vessels

Completed·LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's·Phase 4·NCT00199563·24 enrolled

Mild To Moderate Erectile Dysfunction Study

Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 4·NCT00137072·355 enrolled

Efficacy Study Measuring The Impact Of Treatment With Viagra On The Depressive Symptoms Of Men With Erectile Dysfunction

Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 4·NCT00159809·140 enrolled

Show 3 more trials

Study Of Men With Mild To Moderate Erectile Dysfunction To Evaluate The Efficacy Of Viagra 8 Hours Post-Dose

Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 4·NCT00143260·250 enrolled

Impact Of Viagra On Sexual Satisfaction Of Men With Mild Erectile Dysfunction Who Are Sexually Dissatisfied

Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 4·NCT00301262·183 enrolled

A Study Of The Safety and Efficacy Of Viagra In Men With Erectile Dysfunction Who Do Not Self Identify.

Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 4·NCT00343200·371 enrolled

Oral4 trials

Bioavailability of 3 Sildenafil Oral Disintegrating Tablet Formulations Compared to the Standard Oral Tablet

Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 1·NCT00950404·16 enrolled

Bioequivalence Study For Orally-Disintegrating Tablet Of Sildenafil

Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 1·NCT01737203·53 enrolled

Pharmacokinetics of Sildenafil Following Administration of an Chewable Tablet of Sildenafil Relative to Viagra® Conventional Oral Tablet in Healthy Volunteers

Completed· Hanmi Pharmaceutical Company Limited logo

Hanmi Pharmaceutical Company Limited·Phase 1·NCT01514903·54 enrolled

Show 1 more trial

A Bioequivalence Study of Sildenafil Citrate Orally-Disintegrating Film Dosage Form

Withdrawn·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 1·NCT04391868

Benign Prostatic Hyperplasia1 trial

Effectiveness and Safety of Viagra in Men With ED and LUTS Due to Benign Prostatic Hyperplasia (BPH)

Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 4·NCT00143221·350 enrolled

Endothelial Function1 trial

Effect of Sildenafil on Endothelial Function

Unknown status·RRambam Health Care Campus·N/A·NCT00297544·60 enrolled

ART1 trial

Study to Compare the Effects of Viagra® Vs Hezkue® in Healthy Fasted Male Participants.

Not yet recruiting·AAspargo Labs, Inc·Phase 1·NCT06782659·56 enrolled

5 more indications

Anemia1 trial

Endothelial Function in Patients With Sickle Cell Anemia Before and After Sildenafil

Withdrawn·TThe Baruch Padeh Medical Center, Poriya·Phase 4·NCT00937144·15 enrolled

Chronic Pelvic Pain Syndrome1 trial

Trial of Viagra' in Men With Chronic Pelvic Pain Syndrome Type III

Terminated·UUniversity of Washington·Phase 4·NCT00194597·30 enrolled

Rehabilitation1 trial

Testosterone for Penile Rehabilitation After Radical Prostatectomy

Terminated·MMohit Khera·Phase 1·NCT00848497·3 enrolled

ILD1 trial

A Relative Bioavailability Study Between Two Formulations Of Sildenafil Citrate

Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 1·NCT00904748·47 enrolled

Fasting Conditions1 trial

Bioequivalence Study of Two Formulations of Sildenafil Tablet 100 mg in Healthy Male Volunteers Under Fasting Conditions

Unknown status·PPharmtechnology LLC·Phase 1·NCT04882826·44 enrolled

Sources

References

[1]
ClinicalTrials.gov — 18 trial records for Viagra. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Viagra compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Viagra. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Pfizer's Upjohn has merged with Mylan to form Viatris Inc. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Viagra

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Erectile Dysfunction6 trials

Oral4 trials

Benign Prostatic Hyperplasia1 trial

Endothelial Function1 trial

ART1 trial

Anemia1 trial

Chronic Pelvic Pain Syndrome1 trial

Rehabilitation1 trial

ILD1 trial

Fasting Conditions1 trial

References

Drug Info

Quick Facts

Related News